Work

Adrenergic-Pathway Gene Variants Influence Beta-Blocker–Related Outcomes After Acute Coronary Syndrome in a Race-Specific Manner

Year: 2012

Type: article

Study design: Observational Study

Source: Journal of the American College of Cardiology

DOI: 10.1016/j.jacc.2012.02.051

Authors: Sharon Cresci, Gerald W. Dorn, Philip G. Jones, Amber L. Beitelshees, Allie Y. Li, Petra A. Lenzini, Michael A. Province, John A. Spertus, David E. Lanfear

Institutions: Washington University in St. Louis, University of Missouri–Kansas City, University of Maryland, Baltimore, Henry Ford Hospital

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDGs: Good health and well-being, Reduced inequalities

Open Access status: bronze

Funders: Longer Life Foundation, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Nursing Research

Awards: Pharmacogenetics of the B-type Natriuretic Peptide Pathway, G1944867982, SCCOR in Cardiac Dysfunction and Disease, G3568960569, G4345188664, Genomic variants associated with angina and health status outcome after MI, G6302667831, Impact of Race and Genetic Factors on Beta-blocker Effectiveness in Heart Failure, G8023946508

OpenAlex ID: W1972742428

FWCI: 6.504

Cites: 48

Cited by: 40

Related to: 10